Financial PerformanceINSP reported strong operating leverage and profitability with 4Q sales in line with expectations and material margins/EPS outperformance.
Future Growth PotentialShares remain at an attractive entry point as 2025 tailwinds stack for Inspire, including Inspire V launch, payor coverage for expanded AHI/BMI coverage, and early innings of GLP-1 halo effect and replacement cycle.
Price Target And ValuationAnalyst maintains a Buy rating on INSP with a price target of $230, based on strong sales estimates and raised EPS guidance.